NeuroSense TherapeuticsNRSN 
$0.932.20%24h
2.20%24h
Global rank30257
Market cap$12.71M
Change 7d-11.43%
YTD Performance16.25%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of NeuroSense Therapeutics (NRSN)
As of December 2024, NeuroSense Therapeutics has a market cap of $12.71M. This makes NeuroSense Therapeutics the world's 30257th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of NeuroSense Therapeutics from 2021 to 2024
-
Value:-
Market cap history of NeuroSense Therapeutics from 2021 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $18.86M | 75.80% |
| 2023 | $10.73M | -35.66% |
| 2022 | $16.67M | -50.41% |
| 2021 | $33.62M | - |
NRSN Market Cap Today is $12.71M 2.20% - 13 Dec 2024
View largest stocks by market cap 
